SCHEMBL29456941

SCHEMBL29456941

CCC1(N)CC1(c1ccccc1)C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 11/20 0.44
MAOA P21397 10/20 0.44
GRIN2D O15399 1/20 0.38
GRIN3B O60391 1/20 0.38
GRIN1 Q05586 1/20 0.38
GRIN2A Q12879 1/20 0.38
GRIN2B Q13224 1/20 0.38
GRIN2C Q14957 1/20 0.38
GRIN3A Q8TCU5 1/20 0.38
KDM1A O60341 6/20 0.37
MEN1 O00255 1/20 0.35
CYP1A2 P05177 1/20 0.35
POLB P06746 1/20 0.35
TSHR P16473 1/20 0.35
APEX1 P27695 1/20 0.35
KMT2A Q03164 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
SLC6A4 P31645 1/20 0.35
PNMT P11086 1/20 0.34
TAAR1 Q96RJ0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20548047 0.73 GRIN2D (0.40) MAOBMAOAGRIN2DGRIN3BGRIN1
SCHEMBL5695494 0.71 OPRM1 (0.36) MEN1CYP1A2POLBTSHRAPEX1
SCHEMBL4991848 0.69 TRPA1 (0.36) SLC6A4
SCHEMBL6472118 0.67 AKR1C1 (0.38) POLBSLC6A4
Trifluoroacetic Acid SCHEMBL15667519 0.65 MAOA (0.36) MAOBMAOAPOLBSLC6A4
SCHEMBL22061275 0.64 KIF11 (0.42) SLC6A4
SCHEMBL17143183 0.61 MEN1 (0.40) MAOBMAOAGRIN2DGRIN3BGRIN1
SCHEMBL13685092 0.61 MAOA (0.42) MAOBMAOAMEN1CYP1A2POLB
SCHEMBL17022919 0.61 SLC6A4 (0.39) MAOBMAOAGRIN2DGRIN3BGRIN1
SCHEMBL19717526 0.61 MAOB (0.62) MAOBMAOAPNMTTAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3177612-B1 OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES NUEVOLUTION AS (DK) 2022-02-23 EP disclosed